Characteristics of trophoblastic tissue derived from in vitro culture of preimplantation embryos of the common Marmoset monkey

Placenta ◽  
1987 ◽  
Vol 8 (4) ◽  
pp. 411-422 ◽  
Author(s):  
P.M. Summers ◽  
C.T. Taylor ◽  
J.P. Hearn
Reproduction ◽  
2009 ◽  
Vol 137 (3) ◽  
pp. 517-525 ◽  
Author(s):  
Christina Simon ◽  
Almuth Einspanier

Controversy still exists regarding the involvement of relaxin (RLX) in cervical reorganization throughout parturition in the human, despite its well-known role in facilitating extensive extracellular matrix (ECM) remodeling in diverse organs. Therefore, the aim of the present study was to examine the influence of RLX and estrogen (E2) on the cervical tissue of the common marmoset monkey. Two experimental designs were used: 1)in vivoanalysis of the intracervical diameter under locally applied RLX and 2) ovariectomized (ov) marmosets were treated systemically with either recombinant human (rh) RLX, E2 or rhRLX+E2 to examine their action on the cervix.In vivo-locally applied rhRLX induced a distinct and significant widening of the cervix (before: 4.8±1.1 mm versus after: 5.7±0.9 mm in diameter;P<0.030, MV±s.e.m.). This widening effect was most pronounced in animals without previous pregnancies.In vitroinvestigation of cervical tissue showed significantly increased wet weights after all three hormone treatments (E2: 0.27±0.07 g, RLX: 0.25±0.04 g, E2+RLX: 0.30±0.11 g; allP<0.05; MV±s.e.m.) versus controls (0.10±0.04 g). Furthermore, morphological changes such as loosening of the connective tissue structure and decline in collagen content, an increase in the number of eosinophils, increased the expression of matrix metalloproteinases (MMP1) and MMP2, as well as gene and protein expression of the RLX receptor RXFP1 could be detected in the cervical tissue after all hormone treatments, compared with controls. In summary, RLX has a potent widening effect on the cervix of the common marmoset monkey. Although E2 is not required for this RLX effect, a combined application of E2 and RLX induced the most prominent cervical ripening.


2012 ◽  
Vol 78 (4) ◽  
pp. 811-816 ◽  
Author(s):  
K. Hanazawa ◽  
T. Mueller ◽  
T. Becker ◽  
M. Heistermann ◽  
R. Behr ◽  
...  

Epigenetics ◽  
2017 ◽  
Vol 12 (7) ◽  
pp. 527-539 ◽  
Author(s):  
Daniel Langenstroth-Röwer ◽  
Jörg Gromoll ◽  
Joachim Wistuba ◽  
Ina Tröndle ◽  
Sandra Laurentino ◽  
...  

2011 ◽  
Vol 411 (2) ◽  
pp. 317-322 ◽  
Author(s):  
Inga Bernemann ◽  
Thomas Mueller ◽  
Rainer Blasczyk ◽  
Birgit Glasmacher ◽  
Nicola Hofmann

2017 ◽  
Vol 59 (7) ◽  
pp. 807-821 ◽  
Author(s):  
Karla K. Ausderau ◽  
Caitlin Dammann ◽  
Kathy McManus ◽  
Mary Schneider ◽  
Marina E. Emborg ◽  
...  

Hippocampus ◽  
2004 ◽  
Vol 14 (5) ◽  
pp. 615-627 ◽  
Author(s):  
Helen H.J. Pothuizen ◽  
Joram Feldon ◽  
Ana L. Jongen-Rêlo

2016 ◽  
Vol 2 (1) ◽  
pp. 315-318
Author(s):  
Jan-Cedric Volbers ◽  
Lothar Lauterböck ◽  
Nicola Hofmann ◽  
Birgit Glasmacher

AbstractFor regenerative purposes, there is a high demand for viable and active cells. A big issue is to have enough viable cells available at any given time. One solution is cryopreservation. In this context, DMSO is used as cryoprotective agent (CPA) along with fetal bovine serum for nutrient supply and stress shielding effects. To use these cells for human clinical studies, it is important to eliminate the serum to prevent foreign immune reactions and virus transmittance and DMSO for its toxic effect. In this study a serum free cryopreservation solution and protocol has been established. The combination of methylcellulose and poloxamer 188 provide the basis for the new CPA. Other additves are α-tocopherol, ectoine, prolin and ascorbic acid. The CPAs were examined with 3T3-cells and multipotent stromal cells from the common marmoset monkey (Callithrix jacchus). The cells were preserved with various CPA concentrations, incubation times and different cooling rates. To enable a higher throughput of encouraging conditions a fluorescence microscopy analysis was used. The use of methylcellulose, poloxamer 188 and α-tocopherol enables the reduction of DMSO [up to 2.5% (v/v)] and the elimination of serum without viability losses compared to control.


Sign in / Sign up

Export Citation Format

Share Document